Cancer Cachexia Trends and Forecast
The future of the global cancer cachexia market looks promising with opportunities in the progestogen, corticosteroid, and combination therapy markets. The global cancer cachexia market is expected to reach an estimated $3 billion by 2030 with a CAGR of 4.0% from 2024 to 2030. The major drivers for this market are growing prevalence of cancer cachexia, increasing old age population, and evolving treatment landscape.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Cancer Cachexia by Segment
The study includes a forecast for the global cancer cachexia by mode of action, drugs, distribution channel, and region.
Cancer Cachexia Market by Mode of Action [Shipment Analysis by Value from 2018 to 2030]:
• Appetite Stimulators
• Weight Loss Stabilizers
• Others
Cancer Cachexia Market by Drugs [Shipment Analysis by Value from 2018 to 2030]:
• Progestogens
• Corticosteroids
• Combination Therapies
• Others
Cancer Cachexia Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
• Hospital Stores
• Retail Pharmacy
• Online Pharmacy
Cancer Cachexia Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Cancer Cachexia Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cancer cachexia companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cancer cachexia companies profiled in this report include-
• Aeterna Zentaris
• Aphios
• Bristol-Myers Squibb
• Pfizer
• Helsinn Group
• Merck
• Artelo Biosciences Inc.
• NGM Biopharmaceuticals
• Aveo Oncology
• Aavogen
Cancer Cachexia Market Insights
Lucintel forecasts that appetite stimulator is expected to witness the higher growth over the forecast period due to rise in appetite stimulant research and development for cancer cachexia.
Within this market, progestogen will remain the largest segment due to its excellent efficacy in treating cancer cachexia and their affordable price.
North America will remain the largest region over the forecast period due to the presence of numerous drug makers, as well as the evolving paradigm of cancer care.
Features of the Global Cancer Cachexia Market
Market Size Estimates: Cancer cachexia market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Cancer cachexia market size by mode of action, drugs, distribution channel, and region in terms of value ($B).
Regional Analysis: Cancer cachexia market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different modes of action, drugs, distribution channels, and regions for the cancer cachexia market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cancer cachexia market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the cancer cachexia market size?
Answer: The global cancer cachexia market is expected to reach an estimated $3 billion by 2030.
Q2. What is the growth forecast for cancer cachexia market?
Answer: The global cancer cachexia market is expected to grow with a CAGR of 4.0% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the cancer cachexia market?
Answer: The major drivers for this market are growing prevalence of cancer cachexia, increasing old age population, and evolving treatment landscape.
Q4. What are the major segments for cancer cachexia market?
Answer: The future of the cancer cachexia market looks promising with opportunities in the progestogen, corticosteroid, and combination therapy markets.
Q5. Who are the key cancer cachexia market companies?
Answer: Some of the key cancer cachexia companies are as follows:
• Aeterna Zentaris
• Aphios
• Bristol-Myers Squibb
• Pfizer
• Helsinn Group
• Merck
• Artelo Biosciences Inc.
• NGM Biopharmaceuticals
• Aveo Oncology
• Aavogen
Q6. Which cancer cachexia market segment will be the largest in future?
Answer: Lucintel forecasts that appetite stimulator is expected to witness the higher growth over the forecast period due to rise in appetite stimulant research and development for cancer cachexia.
Q7. In cancer cachexia market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to the presence of numerous drug makers, as well as the evolving paradigm of cancer care.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the cancer cachexia market by mode of action (appetite stimulators, weight loss stabilizers, and others), drugs (progestogens, corticosteroids, combination therapies, and others), distribution channel (hospital stores, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Cancer Cachexia Market, Cancer Cachexia Market Size, Cancer Cachexia Market Growth, Cancer Cachexia Market Analysis, Cancer Cachexia Market Report, Cancer Cachexia Market Share, Cancer Cachexia Market Trends, Cancer Cachexia Market Forecast, Cancer Cachexia Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.